Predictive genetic biomarkers for the efficacy of methotrexate in rheumatoid arthritis: a systematic review
- 17 October 2019
- journal article
- review article
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 20 (2) , 159-168
Abstract
Multiple pharmacogenetic studies investigated the effectiveness of methotrexate. However, due to the use of nonvalidated outcomes, lack of validation or conflicting results it remains unclear if genetic markers can help to predict response to MTX treatment. Therefore, a systematic review was performed. PubMed was searched for articles reporting potential pharmacogenetic biomarkers associated (p < 0.05) with MTX efficacy using the validated endpoints DAS(28), EULAR, or ACR response criteria. The PICO method was used for study selection, and PRISMA guidelines to prepare the report. Thirty-five studies met the inclusion criteria, providing 39 potential genetic biomarkers in 19 genes. After Bonferroni correction, six genetic biomarkers were associated with the efficacy of MTX: ATIC rs7563206; SLC19A1 rs1051266; DHFR rs836788; TYMS rs2244500, rs2847153, and rs3786362 in at least one study. Only SLC19A1 rs1051266 was replicated in an independent cohort and promising for predicting methotrexate efficacy.Keywords
This publication has 44 references indexed in Scilit:
- Race and Methotrexate Pharmacogenetics in Rheumatoid ArthritisThe Journal of Rheumatology, 2010
- Genetic determinants of methotrexate treatment in rheumatoid arthritis patients: a study of polymorphisms in the adenosine pathwayAnnals of the Rheumatic Diseases, 2010
- Gene–gene interactions in folate and adenosine biosynthesis pathways affect methotrexate efficacy and tolerability in rheumatoid arthritisPharmacogenetics and Genomics, 2009
- Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexateRheumatology, 2009
- SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMapBioinformatics, 2008
- Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritisArthritis & Rheumatism, 2008
- A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent‐onset rheumatoid arthritisArthritis & Rheumatism, 2007
- Pharmacogenomic and metabolic biomarkers in the folate pathway and their association with methotrexate effects during dosage escalation in rheumatoid arthritisArthritis & Rheumatism, 2006
- Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent‐onset rheumatoid arthritisArthritis & Rheumatism, 2006
- Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single‐nucleotide polymorphisms in genes coding for folate pathway enzymesArthritis & Rheumatism, 2006